21.06
Kestra Medical Technologies Ltd stock is traded at $21.06, with a volume of 176.38K.
It is down -2.36% in the last 24 hours and down -4.62% over the past month.
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.
See More
Previous Close:
$21.57
Open:
$21.9
24h Volume:
176.38K
Relative Volume:
0.51
Market Cap:
$1.23B
Revenue:
$83.72M
Net Income/Loss:
$-143.89M
P/E Ratio:
-7.4872
EPS:
-2.8128
Net Cash Flow:
$-120.48M
1W Performance:
-13.76%
1M Performance:
-4.62%
6M Performance:
-14.39%
1Y Performance:
+24.10%
Kestra Medical Technologies Ltd Stock (KMTS) Company Profile
Name
Kestra Medical Technologies Ltd
Sector
Industry
Phone
(425) 279-8002
Address
3933 LAKE WASHINGTON BLVD NE, KIRKLAND
Compare KMTS vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
KMTS
Kestra Medical Technologies Ltd
|
21.06 | 1.23B | 83.72M | -143.89M | -120.48M | -2.8128 |
|
ISRG
Intuitive Surgical Inc
|
337.50 | 120.92B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
156.36 | 43.08B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
67.91 | 33.12B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
38.75 | 32.77B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
RMD
Resmed Inc
|
195.27 | 28.33B | 5.54B | 1.52B | 1.74B | 10.37 |
Kestra Medical Technologies Ltd Stock (KMTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-18-25 | Initiated | BTIG Research | Buy |
| Mar-31-25 | Initiated | BofA Securities | Buy |
| Mar-31-25 | Initiated | Goldman | Neutral |
| Mar-31-25 | Initiated | Piper Sandler | Overweight |
| Mar-31-25 | Initiated | Stifel | Buy |
| Mar-31-25 | Initiated | Wells Fargo | Overweight |
| Mar-31-25 | Initiated | Wolfe Research | Outperform |
View All
Kestra Medical Technologies Ltd Stock (KMTS) Latest News
Kestra Medical's Bullish Fundamentals Driven by Large Total Addressable Market, Sustained Share Gains, Oppenheimer Says - marketscreener.com
Oppenheimer initiates Kestra Medical stock rating at Perform By Investing.com - Investing.com South Africa
Kestra Medical Technologies (NASDAQ:KMTS) Coverage Initiated at Oppenheimer - MarketBeat
Oppenheimer Initiates Kestra Medical at Market Perform - Moomoo
Goodwin Guides IP For Pharmakon On Up To $200 Million Financing For Kestra Medical Technologies - Mondaq
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Kestra Medical Technologies, Ltd. Common Stock (NASDAQ: KMTS) Stock Price, News & Analysis - Kalkine
Kestra Medical Technologies, Ltd. (KMTS) reports Q4 loss, tops revenue estimates - MSN
Kestra Medical Technologies Insider Sold Shares Worth $336,609, According to a Recent SEC Filing - Moomoo
Form 4 Kestra Medical Technologies Inc For: 17 July By Investing.com - Investing.com Nigeria
Wall Street Zen Downgrades Kestra Medical Technologies (NASDAQ:KMTS) to Sell - MarketBeat
Kestra Medical Technologies CEO Webster sells $336,609 in stock - Investing.com UK
Kestra Medical CEO Brian Daniel Webster sells USD 333,745 of common shares - Bitget
Form 4 Kestra Medical Technologies Inc For: 17 July - Investing.com India
Kestra Medical Technologies (KMTS) awards 39,113 shares to its CBO - Stock Titan
Kestra Medical Technologies (KMTS) CCO awarded 58,832 performance-based shares - Stock Titan
Kestra Medical Technologies CEO Webster sells $336,609 in stock By Investing.com - Investing.com UK
Kestra Medical (KMTS) CFO receives 44,118 performance-based shares - Stock Titan
Kestra Medical (KMTS) counsel earns 58,832-share stock award - Stock Titan
Kestra Medical Technologies (KMTS) CEO gets 176,470-share award, sells 15,000 - Stock Titan
A Quick Look at Today's Ratings for Kestra Medical Technologies(KMTS.US), With a Forecast Between $30 to $32 - Moomoo
Analysts Offer Insights on NA Companies: Janus Living, Inc. Class A (JAN) and Kestra Medical Technologies Ltd. (KMTS) - The Globe and Mail
Kestra Medical Technologies Earnings Call Highlights Rapid Growth - TipRanks
Kestra Medical Technologies (KMTS) Could Be 31% Overvalued As Earnings And 2027 Guidance Land - simplywall.st
Akin, an Elite Global Law Firm - akingump.com
Kestra Medical Technologies Inc Outlook FY Re - Moomoo
Kestra Medical (NASDAQ: KMTS) investor Brian Webster plans 15,000-share sale - Stock Titan
Kestra Medical Technologies, Ltd. Stock 12‑Month Price Target Raised to $28.43, Implies 18% Upside - TradingView
Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Down 8.7% After Earnings Miss - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Expected to Rise, BTIG Research Analyst Says - MarketBeat
Kestra Medical Technologies secures USD 200M of non-dilutive financing - Medical Buyer
Kestra Medical Technologies, Ltd. Stock 12‑Month Price Target Cut to $27.5, Implies 14% Upside - TradingView
Kestra Medical Technologies Reports Strong Fiscal 2026 Growth - TipRanks
KMTS SWOT Analysis: Key Insights from 10-K Filing - GuruFocus
Earnings call transcript: Kestra Medical posts strong Q4 2026 sales, misses EPS - Investing.com Canada
Kestra Medical secures $75M loan facility with Pharmakon - Investing.com UK
Kestra Medical (KMTS) Q4 2026 Earnings Call Transcript - The Motley Fool
Kestra Medical Technologies Q4 2026 Earnings Call Transcript - MarketBeat
Kestra Medical Technologies (KMTS) Reports Strong Q4 Fiscal 2026 Earnings - GuruFocus
Kestra FY27 outlook set at $137M as Q4 revenue jumps 66% - scanx.trade
Kestra Medical secures $75M loan facility with Pharmakon By Investing.com - Investing.com South Africa
Kestra Medical Technologies Q4 Earnings Call Highlights - MarketBeat
Kestra Medical (NASDAQ: KMTS) targets $24B wearable defibrillator market - Stock Titan
KESTRA MEDICAL TECHNOLOGIES, LTD. FY 2026: Revenue $95.1M, Net income $(131.6M) — 10-K Summary - TradingView
Kestra Medical Technologies : Annual Report for Fiscal Year Ending April 30, 2026 (Form 10-K) - marketscreener.com
Kestra Medical Technologies, Ltd. (KMTS) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Kestra Medical Secures Up to $200 Million in Financing From Pharmakon Advisors - marketscreener.com
Kestra Medical Technologies Ltd reports results for the quarter ended April 30Earnings Summary - TradingView
Kemetics (KMTS) Forecasts Significant Revenue Growth for FY27 - GuruFocus
KMTS: Rapidly scaling cardiac care platform addresses a $10B market with proven outcomes and expanding margins - TradingView
Kestra Medical tops Q4 revenue estimates, but posts wider loss than expected - Investing.com
Kestra Medical Technologies Ltd Stock (KMTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):